Sowell Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Sowell Financial Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37	Closed	-$2K	–	3191
2020 Q4	$2K	Buy	+37	New	+$1.6K	﹤0.01%	2471
2020 Q3	–	Sell	-16,231	Closed	-$616K	–	2612
2020 Q2	$616K	Sell	16,231 -44,160	-73%	-$1.49M	0.03%	399
2020 Q1	$1.62M	Buy	+60,391	New	+$1.72M	0.12%	183

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

RCS

Retirement Capital Strategies San Jose, California $288M AUM 17.43% 1-Year Est. Return

SHJ

Sharkey, Howes & Javer Denver, Colorado $829M AUM 20.38% 1-Year Est. Return

Sowell Financial Services's IDNA Position: Q1 2021 in Review

Sowell Financial Services sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2021, closing a stake of 37 shares — an estimated $2K sold.

Sowell Financial Services first reported a position in IDNA in Q1 2020 and held it in 3 quarters. The position peaked at $1.62M in Q1 2020. 79 funds tracked by Wall St. Rank hold IDNA as of Q1 2021.

Sowell Financial Services reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2021 after selling out during the quarter.
Sowell Financial Services sold 37 iShares Genomics Immunology and Healthcare ETF shares in Q1 2021, an estimated $2K.
Sowell Financial Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2020 and held it in 3 quarters.
Sowell Financial Services's iShares Genomics Immunology and Healthcare ETF position peaked at $1.62M in Q1 2020.
79 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.